Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T84160 | Target Info | |||
Target Name | 5-HT 3 receptor (5HT3R) | ||||
Synonyms |
5-hydroxytryptamine receptor type 3; 5-hydroxytryptamine receptor 3; 5-HT3R; 5-HT3 receptor; 5-HT-3
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | NO-GeName | ||||
Biochemical Class | GPCR rhodopsin | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Serotonin transporter (SERT) | Successful Target | ||||
UniProt ID | SC6A4_HUMAN | |||||
Gene Name | SLC6A4 | |||||
Synonyms |
Solute carrier family 6 member 4; HTT; 5HTT; 5HT transporter
Click to Show/Hide
|
|||||
Representative Drug(s) | LITOXETINE | Drug Info | IC50 = 5.9 nM | [1] | ||
Co-Target Name | 5-HT 3 receptor (5HT3R) | Successful Target | ||||
UniProt ID | 5HT3A_HUMAN; 5HT3B_HUMAN; 5HT3C_HUMAN; 5HT3D_HUMAN; 5HT3E_HUMAN | |||||
Gene Name | NO-GeName | |||||
Synonyms |
5-hydroxytryptamine receptor type 3; 5-hydroxytryptamine receptor 3; 5-HT3R; 5-HT3 receptor; 5-HT-3
Click to Show/Hide
|
|||||
Representative Drug(s) | Ondansetron | Drug Info | Ki = 7.6 nM | [2] | ||
Co-Target Name | Solute carrier family 47 member 1 (SLC47A1) | Successful Target | ||||
UniProt ID | S47A1_HUMAN | |||||
Gene Name | SLC47A1 | |||||
Synonyms |
hMATE-1; Multidrug and toxin extrusion protein 1; MATE1; MATE-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Ondansetron | Drug Info | IC50 < 10 nM | [3] | ||
Co-Target Name | Voltage-gated potassium channel Kv11.1 (KCNH2) | Successful Target | ||||
UniProt ID | KCNH2_HUMAN | |||||
Gene Name | KCNH2 | |||||
Synonyms |
hERG1; hERG-1; Voltage-gated potassium channel subunit Kv11.1; Potassium voltage-gated channel subfamily H member 2; HERG K+ channel; HERG; H-ERG; Ether-a-go-go-related protein 1; Ether-a-go-go-related gene potassium channel 1; Ether-a-go-go related protein 1; Ether-a-go-go related gene potassium channel 1; Eag related protein 1; Eag homolog; ERG-1; ERG
Click to Show/Hide
|
|||||
Representative Drug(s) | Ondansetron | Drug Info | IC50 = 400 nM | [4] | ||
Co-Target Name | Multidrug and toxin extrusion protein 2 (MATE2) | Literature-reported Target | ||||
UniProt ID | S47A2_HUMAN | |||||
Gene Name | SLC47A2 | |||||
Synonyms |
hMATE-2; Solute carrier family 47 member 2; MATE2; MATE-2; Kidney-specific H(+)/organic cation antiporter
Click to Show/Hide
|
|||||
Representative Drug(s) | Ondansetron | Drug Info | IC50 = 160 nM | [3] | ||
Co-Target Name | Solute carrier family 22 member 2 (SLC22A2) | Co-Target | ||||
UniProt ID | S22A2_HUMAN | |||||
Gene Name | SLC22A2 | |||||
Synonyms |
Organic cation transporter 2; hOCT2
Click to Show/Hide
|
|||||
Representative Drug(s) | Ondansetron | Drug Info | IC50 = 890 nM | [5] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Bioorg Med Chem Lett. 2009 Oct 15;19(20):5893-7. Epub 2009 Aug 21.Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2. | ||||
REF 2 | 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome. J Med Chem. 1993 Oct 29;36(22):3286-92. | ||||
REF 3 | Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. J Med Chem. 2013 Feb 14;56(3):781-795. | ||||
REF 4 | Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists. Bioorg Med Chem Lett. 2010 Nov 15;20(22):6538-41. | ||||
REF 5 | Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. J Med Chem. 2011 Jul 14;54(13):4548-58. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.